Physician profile
Avital Hahn
NPI 1578095956
$3,231.70
in general payments reported to CMS, 2019-2025
22 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.66 · 2021: $207 · 2022: $140 · 2023: $1,817 · 2024: $763 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,914 · Travel and Lodging: $955 · Education: $1.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,914.36 |
| Travel and Lodging | $955.24 |
| Education | $1.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,168.93 | 2023 | Enseal |
| Baxter Healthcare | $380.34 | 2023-2025 | Tisseel |
| Intuitive Surgical, INC. | $246.55 | 2023-2025 | Da Vinci Surgical System |
| Gynesonics, INC. | $156.65 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $156.01 | 2024-2025 | Veozah |
| Ethicon US, LLC | $142.17 | 2022-2023 | Enseal |
| Myovant Sciences INC. | $124.74 | 2021 | |
| Abbvie INC. | $124.53 | 2021-2023 | |
| Pfizer INC. | $124.23 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $97.28 | 2024-2025 | Myfembree, Gemtesa |
| Hologic Sales and Service, LLC | $95.84 | 2022-2024 | Acessa Provu System, Novasure, Aptima |
| Mayne Pharma Commercial LLC | $86.81 | 2023-2025 | |
| Biogen, INC. | $81.15 | 2024-2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $42.10 | 2023-2024 | Gardasil 9, Gardasil |
| Exeltis, USA INC. | $40.98 | 2023-2024 | Slynd |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $37.01 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Organon LLC | $34.20 | 2023-2025 | Nexplanon, Jada System |
| Exact Sciences Corporation | $30.18 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $18.38 | 2023 | |
| Agile Therapeutics, INC. | $15.58 | 2023 | Twirla |
| Avion Pharmaceuticals | $14.38 | 2023 | Balcoltra |
| Tesaro, INC. | $13.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avital Hahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.